Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)

Study Identifier
CMO-MA-EYE-0590
CT.gov Identifier
NCT03868254
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Protocol
Available Language(s): English
Download document(s)
Statistical Analysis Plan
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Glaucoma - Other
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    Inclusion Criteria: * Eye treated with XEN 45 Gel Stent for primary open angle glaucoma as a standalone procedure or in combination with phacoemulsification * XEN 45 Gel Stent was implanted between 1 January 2014 and 1 October 2015 Exclusion Criteria * None

    Protocol Summary

    A retrospective, non-interventional, observational, multi-center, chart review study to be conducted in participants who underwent placement of the XEN 45 Gel Stent as a standalone procedure or in combination with phacoemulsification from 1 January 2014 to 1 October 2015.

    Study Locations

    Location
    Status
    Location
    Clinical Trials Registry Team
    Irvine, California, United States, 92622
    Status
    Not applicable